Mason Street Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-47,527
Closed -$2.39M 21
2020
Q4
$2.39M Sell
47,527
-87
-0.2% -$3.47K 0.04% 523
2020
Q3
$1.4M Sell
47,614
-1,126
-2% -$32.7K 0.03% 682
2020
Q2
$1.22M Buy
48,740
+1,631
+3% +$40.7K 0.02% 737
2020
Q1
$864K Hold
47,109
0.02% 789
2019
Q4
$1.56M Buy
47,109
+684
+1% +$21.4K 0.03% 711
2019
Q3
$1.44M Sell
46,425
-854
-2% -$26K 0.03% 707
2019
Q2
$1.65M Buy
47,279
+241
+0.5% +$7.79K 0.03% 656
2019
Q1
$1.38M Buy
47,038
+809
+2% +$22.9K 0.03% 766
2018
Q4
$1.19M Buy
46,229
+891
+2% +$30.8K 0.03% 739
2018
Q3
$1.6M Buy
45,338
+3,251
+8% +$130K 0.03% 692
2018
Q2
$1.72M Buy
42,087
+1,005
+2% +$40.5K 0.04% 639
2018
Q1
$1.61M Buy
41,082
+841
+2% +$30.8K 0.04% 642
2017
Q4
$1.31M Sell
40,241
-300
-0.7% -$10.4K 0.03% 756
2017
Q3
$1.94M Buy
40,541
+3,214
+9% +$157K 0.05% 527
2017
Q2
$1.84M Buy
+37,327
New +$1.65M 0.05% 542

Other funds holding ACHC

Mason Street Advisors's ACHC Position: Q1 2021 in Review

Mason Street Advisors sold out of Acadia Healthcare (ACHC) in Q1 2021, closing a stake of 47,527 shares — an estimated $2.39M sold.

Mason Street Advisors first reported a position in ACHC in Q2 2017 and held it in 15 quarters. The position peaked at $2.39M in Q4 2020. 271 funds tracked by Wall St. Rank hold ACHC as of Q1 2021.

  • Mason Street Advisors reported no remaining Acadia Healthcare position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 47,527 Acadia Healthcare shares in Q1 2021, an estimated $2.39M.
  • Mason Street Advisors first reported a position in Acadia Healthcare in Q2 2017 and held it in 15 quarters.
  • Mason Street Advisors's Acadia Healthcare position peaked at $2.39M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.